SCHEMBL23047643

SCHEMBL23047643

C=C[C@H](N)C(=O)OCC(CC)CC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.45
CYP3A4 P08684 2/20 0.36
ATM Q13315 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CYP2D6 P10635 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP2C9 P11712 1/20 0.33
RECQL P46063 1/20 0.33
ALDH1A1 P00352 2/20 0.32
CA2 P00918 1/20 0.32
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
BLM P54132 1/20 0.31
SLC6A3 Q01959 1/20 0.31
MEN1 O00255 1/20 0.31
NFKB1 P19838 1/20 0.31
KMT2A Q03164 1/20 0.31
PRSS1 P07477 1/20 0.30
PRSS2 P07478 1/20 0.30
PRSS3 P35030 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6765361 0.79
SCHEMBL12544684 0.79
SCHEMBL807502 0.75 CYP3A4 (0.40) TSHRCYP3A4ATMTDP1CYP2D6
SCHEMBL28854881 0.75 TSHR (0.42) TSHRCYP3A4ATMTDP1RECQL
SCHEMBL25526434 0.75 CYP3A4 (0.40) TSHRCYP3A4ATMTDP1CYP2D6
SCHEMBL14989535 0.75 CYP3A4 (0.40) TSHRCYP3A4ATMTDP1CYP2D6
SCHEMBL26276677 0.75 TSHR (0.42) TSHRCYP3A4ATMTDP1RECQL
Hydrochloric Acid SCHEMBL16698594 0.74 CYP3A4 (0.39) TSHRCYP3A4ATMTDP1CYP2D6
Hydrochloric Acid SCHEMBL28854856 0.74 TSHR (0.41) TSHRCYP3A4ATMTDP1RECQL
Hydrochloric Acid SCHEMBL1273080 0.74 CYP3A4 (0.39) TSHRCYP3A4ATMTDP1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3785717-B1 METHODS FOR TREATING CORONAVIRIDAE INFECTIONS GILEAD SCIENCES INC (US) 2022-01-05 EP disclosed
EP-3785717-A1 METHODS FOR TREATING CORONAVIRIDAE INFECTIONS Gilead Sciences, Inc. (US) 2021-03-03 EP disclosed